Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Cousins Properties
CUZ
$5.22B
| – | – |
-436,372
| Closed | -$12.9M |
|
3277
Cemex
CX
$17.3B
| – | – |
-6,195,333
| Closed | -$47.3M |
|
3278
Danaos Corp
DAC
$2.56B
| – | – |
-3,464
| Closed | -$130K |
|
3279
Dell
DELL
$253B
| – | – |
-1,862,298
| Closed | -$25M |
|
3280
Diageo
DEO
$49.4B
| – | – |
-293,800
| Closed | -$34.1M |
|
|
DFS
3281
DELISTED
Discover Financial Services
DFS
| – | – |
-237,600
| Closed | -$13.4M |
|
3282
Dollar General
DG
$27.8B
| – | – |
-237,900
| Closed | -$16.7M |
|
3283
DHT Holdings
DHT
$2.99B
| – | – |
-272,500
| Closed | -$1.14M |
|
3284
Dine Brands
DIN
$458M
| – | – |
-72,500
| Closed | -$5.74M |
|
3285
Duluth Holdings
DLTH
$163M
| – | – |
-25,300
| Closed | -$671K |
|
3286
Dycom Industries
DY
$12.1B
| – | – |
-359,800
| Closed | -$29.4M |
|
3287
Electronic Arts
EA
$52.4B
| – | – |
-294,964
| Closed | -$25.2M |
|
3288
eBay
EBAY
$52.1B
| – | – |
-5,474,640
| Closed | -$180M |
|
3289
Ecolab
ECL
$79.6B
| – | – |
-139,622
| Closed | -$17M |
|
3290
Editas Medicine
EDIT
$402M
| – | – |
-128,400
| Closed | -$1.73M |
|
|
ELP
3291
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| – | – |
-35,750
| Closed | -$148K |
|
3292
Emcor
EME
$31.4B
| – | – |
-26,200
| Closed | -$1.56M |
|
3293
Enel Chile
ENIC
$6.05B
| – | – |
-214,700
| Closed | -$1.02M |
|
3294
EQT Corp
EQT
$32.3B
| – | – |
-150,634
| Closed | -$5.96M |
|
3295
Ericsson
ERIC
$32.7B
| – | – |
-1,150,400
| Closed | -$8.29M |
|
|
ESPR
3296
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-318,800
| Closed | -$4.42M |
|
|
EVOK
3297
DELISTED
Evoke Pharma
EVOK
| – | – |
-833
| Closed | -$271K |
|
3298
iShares MSCI Japan ETF
EWJ
$21.3B
| – | – |
-31,200
| Closed | -$1.56M |
|
3299
iShares MSCI South Korea ETF
EWY
$21.1B
| – | – |
-20,500
| Closed | -$1.19M |
|
|
EXAS
3300
DELISTED
Exact Sciences
EXAS
| – | – |
-365,300
| Closed | -$6.78M |
|
Similar funds
Renaissance Technologies's Q4 2016 Portfolio in Review
As of Q4 2016, Renaissance Technologies held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Renaissance Technologies deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Renaissance Technologies's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Renaissance Technologies's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Renaissance Technologies fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Renaissance Technologies's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Renaissance Technologies opened 418 new positions and closed 494 in Q4 2016.
- Renaissance Technologies's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.